Aptinyx

Biotechs put assets up for sale and on the shelf in quarterly pipeline clear-outs
Fierce Biotech
Wed, 11/9/22 - 10:53 am
Xilio Therapeutics
Protagonist Therapeutics
Arbutus BioPharma
Aptinyx
Drug makers leave the pain behind
EP Vantage
Fri, 08/26/22 - 10:26 am
painkillers
Acadia
Eli Lilly
Ampio Pharmaceuticals
Aptinyx
Eliem Therapeutics
Vertanical
Teva Pharamceutical
Regeneron
Vivozon
Vertex Pharmaceuticals
Biogen
Aptinyx Suffers Defeat in Diabetic Peripheral Neuropathy as Drug Fails Endpoint
BioSpace
Thu, 04/7/22 - 06:11 pm
Aptinyx
NYX-2925
diabetic peripheral neuropathy
clinical trials
Aptinyx Moves Ahead With PTSD Therapy Study, Pauses 3 Other Trials
Xconomy
Wed, 04/1/20 - 10:12 am
Aptinyx
clinical trials
PTSD
COVID-19
Aptinyx's lead drug makes cut in small fibromyalgia trial, setting the stage for larger chronic pain study
Endpoints
Mon, 06/10/19 - 10:33 am
Aptinyx
clinical trials
fibromyalgia
NYX-2925
Aptinyx stung by pain drug's mid-stage miss
BioPharma Dive
Wed, 01/16/19 - 11:49 pm
Aptinyx
diabetic peripheral neuropathy
clinical trials
NYX-2925
Bio IPO Madness: Six Biotech Startups Raise $568M in 24 Hours
Xconomy
Thu, 06/21/18 - 12:04 pm
biotech
IPOs
Eidos Therapeutics
Avrobio
XERIS
Aptinyx
Kezar Life Sciences
Magenta Therapeutics